Forskrifter
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
FDA
MHRA
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO-liste
Kliniske studier
US Clinical Trials Registry
EUs kliniske prøveregister
Farmasøytiske selskaper
Clinical Research Labs
Tjenestebedrifter
Clinical Research Events
Publikasjoner
Forskere
Arbeidsplasser
Publikasjoner
Nyheter
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til
engelsk versjon
for en kildetekst.
ICH GCP
US Clinical Trials Registry
Search trials
Tilstand eller sykdom:
Intervensjon/behandling:
Sponsor:
Plassering:
Kun rekruttering og ennå ikke rekrutteringsstudier
Søk i kliniske studier for: Placebo/ CONCERTA (metylfenidat HCl)
Totalt 0 resultater
Ingenting funnet
Sponsorer og samarbeidspartnere
Health Information Technology Solutions (HITS) LLC
Shanghai GeneChem Co., Ltd.
The Affiliated Hospital of Xuzhou Medical University
Zhongda Hospital, Medical School, Southeast University
Nutrabolt
Pia Jaeger, MD, PhD
Smart Meter Corporation
Impulse Dynamics, Inc.
Salena Killion
Université de Genève (UNIGE)
UNITI Consortium
Hungarian Dental Association
HBSA
Cogniciti
Vivid Pharma Inc.
NERv Technology Inc
BioNova Pharmaceuticals (Shanghai) LTD.
Defence Services Medical Academy (DSMA), Myanmar
Huisartspraktijk Handellaan
Ministry of Public Health, Cameroon
Vis full liste
Medisinsk tilstand
Metabolsk kirurgi
Spontan intracerebral blødning
Karsinom, nyrecelle (kun klare celler)
Sigmoide sykdommer
Ciliary Body og Choroid Melanom, Medium/Large Størrelse
Tannpleier
Depressiv sykdom
Kronisk lomboradiculalgi
Motor Vehicle Occupant Injury
Revisjon av total hofteprotese
Kvinnelig proteinmetabolisme
Duodenitt
Symptomatisk ventrikulær asystoli
Methylmalonic aciduria, cblB Type
Ventrikuloperitoneal shunt
Lungebetennelse, Ventilator-assosiert
Ankel; Skade, overfladisk, multippel (med fot)
Kronisk afasi
Fase I prostataadenokarsinom AJCC v7
Mitokondriell kardiomyopati
Vis full liste
Legemiddelintervensjoner
5 FU kontinuerlig
0,75 % ropivakain
Olopatadinhydroklorid 0,2 %
Rosuvastatin
Microneedling med aktuell glykolsyre 35%.
20 mg/kg IV FL-301
Acetylsalisylsyre
Fase B: Triplixam / Elestar HCT
Oksymorfonhydroklorid (HCl)
TQB2450
Durvalumab + cellegiftbehandling
CJ-12420 200 mg + klaritromycin 500 mg
CNTO 6785 50 mg
Cefadroxil til avløpet er fjernet
OXP005
Lacosamid
INT-747
18F-FDG
HPN328
80% oxygen
Vis full liste
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Canada
Contract Research Organizations in Chile
Contract Research Organizations in Congo
Contract Research Organizations in Hungary
Contract Research Organizations in Israel
Contract Research Organizations in Kuwait
Contract Research Organizations in Mali
Contract Research Organizations in Mauritania
Contract Research Organizations in Mauritius
Contract Research Organizations in Moldova
Contract Research Organizations in Pakistan
Contract Research Organizations in Trinidad & Tobago
CRO list by country
CROs in Pakistan
MAC Clinical Research®
ACROSS Global
IQVIA
Dimension Research
Metrics Research
DRK Pharma Solutions
SGS
Cyntax Health Projects Pvt Ltd
Orci Trials Ltd
Dow Institute of Biological Biochemical & Pharmaceutical Sciences (IBBPS)
All CROs in Pakistan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Abonner for å motta varsler om reguleringsoppdateringer og bransjenyheter!
Abonnere
GOOD CLINICAL PRACTICE NETWORK
Abonner for å motta varsler om reguleringsoppdateringer og bransjenyheter!
Abonnere
Abonnere